AACR Annual Meeting 2022 - Biognosys

AACR Annual Meeting 2022

We are extremely excited about our presence at AACR 2022! Kristina Beeler, our Chief Business Officer, invites you to learn more about how proteomics is transforming cancer research.

 

 

 

At this year’s AACR Annual Meeting, Biognosys had a strong presence with an oral presentation, five posters and one collaborator poster by NeoGenomics.

 

Biognosys' Presentations at AACR 2022

Resource - Posters
Ubiquitin Ligases Implicated as Predictive Biomarkers for Poor Outcome to Immunotherapy in Melanoma Patients

Poster presented at AACR[...]

READ MORE
Resource - Posters
Discovery of MHC Class I and Class II Neoantigens in Lung Cancer in Needle Biopsy Tissue Samples Using an Optimized High-throughput Workflow

Poster presented at AACR[...]

READ MORE
Resource - Posters
Target Identification, Selectivity Profiling and Mechanistic Insights of a CDK9 Inhibitor Using Complementary Proteomics Methods

Poster presented at AACR[...]

READ MORE
Resource - Posters
Identification of the Phosphorylation Network in PDX and Corresponding Organoid (PDXO) Models Upon Targeted Therapy Treatment Using Deep Phosphoproteomic Analysis

Poster presented at AACR[...]

READ MORE
Resource - Posters
Precise Solid Tumor Classification Through Unbiased Quantification of Proteoforms Deep into Tissue Leakage

Poster presented at AACR[...]

READ MORE
Resource - Posters
Dual Approach Using Unbiased Proteomics and Multiplexed Immunofluorescence for the Detection of Markers Predictive for Immunotherapy in Melanoma Patients

Poster presented at AACR[...]

READ MORE
Resource - Presentations
Prediction of Small Molecule-protein Binding Events for BRD4 and EGFR Inhibitors Using HR-LiP, a Novel Structural Proteomics Approach

Presenter: Yuehan Feng Oral Presentation at AACR[...]

READ MORE

Contact

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More